Influence of an additional application of iodine-127 on the pharmacokinetics of radioactive iodine-131 during a radioiodine therapy in patients with Graves' disease.

被引：0
|
作者：
Moka, D [1 ]
Reinholz, U [1 ]
Eschner, W [1 ]
Wellner, U [1 ]
Schicha, H [1 ]
机构：
[1] Univ Cologne, D-5000 Cologne 41, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2003年 / 44卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1189
引用
收藏
页码：332P / 333P
页数：2
相关论文
共 50 条
  • [31] THE EVALUATION OF I-131 THERAPY OF GRAVES DISEASE - RELIABILITY AND PROGNOSTIC VALUE OF CHEMICAL AND RADIOACTIVE IODINE STUDIES
    DOMNITZ, J
    HURD, HF
    GOLDZIEHER, JW
    ARCHIVES OF INTERNAL MEDICINE, 1960, 106 (02) : 194 - 204
  • [32] The likely transformation of papillary thyroid carcinoma into anaplastic carcinoma during postoperative radioactive iodine-131 therapy: Report of a case
    Kiyoshi Shingu
    Shinya Kobayashi
    Shiro Yokoyama
    Minoru Fujimori
    Kazuhiko Asanuma
    Ken-ichi Ito
    Yoshihisa Hama
    Masayuki Maruyama
    Ritsu Kusama
    Jun Amano
    Surgery Today, 2000, 30 : 910 - 913
  • [33] The likely transformation of papillary thyroid carcinoma into anaplastic carcinoma during postoperative radioactive iodine-131 therapy: Report of a case
    Shingu, K
    Kobayashi, S
    Yokoyama, S
    Fujimori, M
    Asanuma, K
    Ito, K
    Hama, Y
    Maruyama, M
    Kusama, R
    Amano, J
    SURGERY TODAY, 2000, 30 (10) : 910 - 913
  • [34] Recurrence-free survival and prognosis after adjuvant therapy with radioactive iodine-131 in patients with differentiated thyroid carcinoma
    Iizuka, Yusuke
    Katagiri, Tomohiro
    Ogura, Kengo
    Inoue, Minoru
    Nakashima, Ryota
    Nakamura, Kiyonao
    Mizowaki, Takashi
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [35] Recurrence-free survival and prognosis after adjuvant therapy with radioactive iodine-131 in patients with differentiated thyroid carcinoma
    Yusuke Iizuka
    Tomohiro Katagiri
    Kengo Ogura
    Minoru Inoue
    Ryota Nakashima
    Kiyonao Nakamura
    Takashi Mizowaki
    Scientific Reports, 13
  • [36] Inappropriate probe positioning during radioactive iodine uptake measurements cause inaccurate 131I quantification in patients with Graves' disease
    Zeng, J.
    Zhang, T.
    Yang, Y.
    Wang, J.
    Han, X.
    Guo, Q.
    Fang, Y.
    INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2024, 22 (02):
  • [37] Predictive Value of a Thyroid-Absorbed Dose with a Shorter Effective Half-Life on Efficacy in Graves Disease Patients Receiving Iodine-131 Therapy
    Yu, Feng
    Zhang, Ruiguo
    Zhang, Guizhi
    Meng, Zhaowei
    Liu, Xiaohua
    He, Yajing
    Tan, Jian
    Wang, Renfei
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [38] The outcome of patients with relapsed or refractory Graves' disease and hyperfunctioning uni- or multinodular goiter after a personalized dose of Iodine-131
    Florimonte, L.
    Butti, I.
    Pagani, L.
    Di Leo, C.
    Maffioli, L. S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S334 - S334
  • [39] Recurrence-free survival and prognostic factors after adjuvant therapy with radioactive iodine-131 in patients with differentiated thyroid carcinoma
    Iizuka, Y.
    Katagiri, T.
    Ogura, K.
    Inoue, M.
    Nakamura, K.
    Mizowaki, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S364 - S364
  • [40] Identification of patients with Graves' disease who benefit from high-dose radioactive iodine therapy
    Watanabe, Shiro
    Okamoto, Shozo
    Akikawa, Kazumasa
    Miyamoto, Noriyuki
    Okamura-Kawasaki, Miyuki
    Uchiyama, Yuko
    Takenaka, Junki
    Toyonaga, Takuya
    Hirata, Kenji
    Kudo, Kohsuke
    ANNALS OF NUCLEAR MEDICINE, 2022, 36 (11) : 923 - 930
12345